Biofrontera mulls US IPO to fund skin cancer drugGerman biotech Biofrontera is considering a US stock market listing to fund development and marketing of a skin Share XBiofrontera mulls US IPO to fund skin cancer drughttps://pharmaphorum.com/news/biofrontera-considers-us-listing-fund-skin-cancer-drug/
